Laping NJ - Search Results

1

Effects of angiotensins II and IV on blood pressure, renal function, and PAI-1 expression in the heart and kidney of the rat.

Abrahamsen CT, Pullen MA, Schnackenberg CG, Grygielko ET, Edwards RM, Laping NJ, Brooks DP. Abrahamsen CT, et al. Among authors: laping nj. Pharmacology. 2002 Sep;66(1):26-30. doi: 10.1159/000063252. Pharmacology. 2002. PMID: 12169762

2

Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis.

Grygielko ET, Martin WM, Tweed C, Thornton P, Harling J, Brooks DP, Laping NJ. Grygielko ET, et al. Among authors: laping nj. J Pharmacol Exp Ther. 2005 Jun;313(3):943-51. doi: 10.1124/jpet.104.082099. Epub 2005 Mar 15. J Pharmacol Exp Ther. 2005. PMID: 15769863

3

The angiotensin type 1 receptor antagonist, eprosartan, attenuates the progression of renal disease in spontaneously hypertensive stroke-prone rats with accelerated hypertension.

Abrahamsen CT, Barone FC, Campbell WG Jr, Nelson AH, Contino LC, Pullen MA, Grygielko ET, Edwards RM, Laping NJ, Brooks DP. Abrahamsen CT, et al. Among authors: laping nj. J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21. J Pharmacol Exp Ther. 2002. PMID: 11907153

4

Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reduction.

Olson BA, Ali SM, Contino LC, Brooks DP, Laping NJ. Olson BA, et al. Among authors: laping nj. Pharmacology. 1998 Jul;57(1):13-9. doi: 10.1159/000028221. Pharmacology. 1998. PMID: 9670208

5

The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production.

Butter S, Laping NJ, Pullen M, Grygielko E, Olson B, Brooks DP. Butter S, et al. Among authors: laping nj. Eur J Pharmacol. 2001 Jun 22;422(1-3):47-52. doi: 10.1016/s0014-2999(01)01072-x. Eur J Pharmacol. 2001. PMID: 11430912

6

Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.

Ali SM, Laping NJ, Fredrickson TA, Contino LC, Olson Ba, Anderson K, Brooks DP. Ali SM, et al. Among authors: laping nj. Pharmacology. 1998 Jul;57(1):20-7. doi: 10.1159/000028222. Pharmacology. 1998. PMID: 9670209

7

Renal vasopressin receptor expression and function in rats following spaceflight.

Brooks DP, Nambi P, Laping NJ, Olson BA, Pullen M, Wade CE. Brooks DP, et al. Among authors: laping nj. J Appl Physiol (1985). 2000 Apr;88(4):1316-20. doi: 10.1152/jappl.2000.88.4.1316. J Appl Physiol (1985). 2000. PMID: 10749825 Free article.

8

Gene expression in rats with renal disease treated with the angiotensin II receptor antagonist, eprosartan.

Wong VY, Laping NJ, Contino LC, Olson BA, Grygielko E, Brooks DP. Wong VY, et al. Among authors: laping nj. Physiol Genomics. 2000 Nov 9;4(1):35-42. doi: 10.1152/physiolgenomics.2000.4.1.35. Physiol Genomics. 2000. PMID: 11074011

9

Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.

Wong VY, Laping NJ, Nelson AH, Contino LC, Olson BA, Gygielko E, Campbell WG Jr, Barone F, Brooks DP. Wong VY, et al. Among authors: laping nj. Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329. Br J Pharmacol. 2001. PMID: 11682445 Free PMC article.

10

Role of caspases in human renal proximal tubular epithelial cell apoptosis.

Wong VY, Keller PM, Nuttall ME, Kikly K, DeWolf WE Jr, Lee D, Ali SM, Nadeau DP, Grygielko ET, Laping NJ, Brooks DP. Wong VY, et al. Among authors: laping nj. Eur J Pharmacol. 2001 Dec 21;433(2-3):135-40. doi: 10.1016/s0014-2999(01)01517-5. Eur J Pharmacol. 2001. PMID: 11755144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page